GS
FRTX

GTS Securities’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

GTS Securities’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-50,100
Closed -$48.6K – 4523
2023
Q3 		$48.6K Buy
+50,100
New +$35.4K ﹤0.01% 3706

Other funds holding FRTX

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

GTS Securities's FRTX Position: Q4 2023 in Review

GTS Securities sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2023, closing a stake of 50,100 shares — an estimated $48.6K sold.

GTS Securities first reported a position in FRTX in Q3 2023 and held it in 1 quarter. The position peaked at $48.6K in Q3 2023. 1 fund tracked by Wall St. Rank holds FRTX as of Q4 2023.

  • GTS Securities reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • GTS Securities sold 50,100 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $48.6K.
  • GTS Securities first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • GTS Securities's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $48.6K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2023.

Based on GTS Securities's 13F filing for Q4 2023, filed 15 Feb 2024.